Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Lupin Gains 3%; BSE HEALTHCARE Index Up 0.4%
Fri, 9 Aug 13:30

Lupin Gains 3%; BSE HEALTHCARE Index Up 0.4%Image source: Chunumunu/www.istockphoto.com

Lupin share price has zoomed 3% and is presently trading at Rs 2,113.4.

Meanwhile, the BSE HEALTHCARE index is at 41,093.6 (up 0.4%).

Among the top gainers in the BSE HEALTHCARE index today are ERIS LIFESCIENCES (up 2.3%) and GLAND PHARMA (up 2.2%).

ALEMBIC PHARMA (down 5.0%) and FDC (down 1.8%) are among the top losers today.

Over the last one year, Lupin has moved up from Rs 1,081.4 to Rs 2,113.4, registering a gain of Rs 1,032.0 (up 95.4%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,300.0 to 41,093.6, registering a gain of 45.2% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 115.0%), GSK Pharma (up 107.4%) and GRANULES INDIA (up 106.8%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 79,703.1 (up 1.0%).

The top gainers among the BSE Sensex today are Tata Motors (up 2.9%) and JSW Steel (up 2.9%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,371.1 (up 1.1%). Eicher Motor and Grasim Industries are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,953.5 to 79,703.1, registering a gain of 13,749.6 points (up 20.8%).

Lupin Financial Update...

Lupin net profit grew 77.7% YoY to Rs 8,055 million for the quarter ended June 2024, compared to a profit of Rs 4,533 million a year ago. Net sales rose 16.3% to Rs 56,003 million during the period as against Rs 48,141 million in April-June 2023.

For the year ended March 2024, Lupin reported 332.3% increase in net profit to Rs 19,356 million compared to net profit of Rs 4,477 million during FY23. Revenue of the company grew 20.2% to Rs 200,108 million during FY24.

The current Price to earnings ratio of Lupin, based on rolling 12 month earnings, stands at 42.1.


Equitymaster requests your view! Post a comment on "Lupin Gains 3%; BSE HEALTHCARE Index Up 0.4%". Click here!